Published in J Clin Oncol on May 01, 1991
Antiviral therapy: current concepts and practices. Clin Microbiol Rev (1992) 0.96
Combination of ganciclovir and granulocyte-macrophage colony-stimulating factor in the treatment of cytomegalovirus retinitis in AIDS patients. The ACTG 073 Team. Eur J Clin Microbiol Infect Dis (1994) 0.79
Granulocyte-macrophage colony-stimulating factor as an immune-based therapy in HIV infection. J Immune Based Ther Vaccines (2005) 0.76
Acquired immune deficiency syndrome-related Kaposi's sarcoma. J Clin Oncol (1991) 0.75
The capsaicin receptor: a heat-activated ion channel in the pain pathway. Nature (1997) 30.59
The efficacy of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. A double-blind, placebo-controlled trial. N Engl J Med (1987) 13.84
Molecular characterization of human T-cell leukemia (lymphotropic) virus type III in the acquired immune deficiency syndrome. Science (1984) 10.40
Synaptic vesicle exocytosis captured by quick freezing and correlated with quantal transmitter release. J Cell Biol (1979) 8.78
The toxicity of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. A double-blind, placebo-controlled trial. N Engl J Med (1987) 8.52
HTLV-III infection in brains of children and adults with AIDS encephalopathy. Science (1985) 7.70
Isolation of HTLV-III from cerebrospinal fluid and neural tissues of patients with neurologic syndromes related to the acquired immunodeficiency syndrome. N Engl J Med (1985) 6.54
Sites of microtubule assembly and disassembly in the mitotic spindle. Cell (1986) 5.91
Estimation of the clinically diagnosed proportion of sleep apnea syndrome in middle-aged men and women. Sleep (1997) 5.66
Neutralization of the AIDS retrovirus by antibodies to a recombinant envelope glycoprotein. Science (1986) 5.25
Pericentrin, a highly conserved centrosome protein involved in microtubule organization. Cell (1994) 5.09
Blocking of HIV-1 infectivity by a soluble, secreted form of the CD4 antigen. Science (1987) 4.31
Characterization of monoclonal antibodies reactive with murine leukemia viruses: use in analysis of strains of friend MCF and Friend ecotropic murine leukemia virus. Virology (1983) 4.16
Gamma-tubulin is a highly conserved component of the centrosome. Cell (1991) 4.15
The mechanism of placebo analgesia. Lancet (1978) 4.10
Designing CD4 immunoadhesins for AIDS therapy. Nature (1989) 4.00
Epileptic seizures may begin hours in advance of clinical onset: a report of five patients. Neuron (2001) 3.91
Virus envelope protein of HTLV-III represents major target antigen for antibodies in AIDS patients. Science (1985) 3.81
Seroepidemiological studies of human T-lymphotropic retrovirus type III in acquired immunodeficiency syndrome. Lancet (1984) 3.77
Human T lymphotropic virus type III infection of human alveolar macrophages. Blood (1986) 3.66
Impact of cancer-related fatigue on the lives of patients: new findings from the Fatigue Coalition. Oncologist (2000) 3.62
HTLV-III in saliva of people with AIDS-related complex and healthy homosexual men at risk for AIDS. Science (1984) 3.50
The acquired immunodeficiency syndrome. Ann Intern Med (1983) 3.49
HTLV-III in cells cultured from semen of two patients with AIDS. Science (1984) 3.47
Patient, caregiver, and oncologist perceptions of cancer-related fatigue: results of a tripart assessment survey. The Fatigue Coalition. Semin Hematol (1997) 3.27
A new HTLV-III/LAV protein encoded by a gene found in cytopathic retroviruses. Science (1986) 3.20
A new HTLV-III/LAV encoded antigen detected by antibodies from AIDS patients. Science (1985) 3.05
A human serum mannose-binding protein inhibits in vitro infection by the human immunodeficiency virus. J Exp Med (1989) 2.95
The alpha-chemokine, stromal cell-derived factor-1alpha, binds to the transmembrane G-protein-coupled CXCR-4 receptor and activates multiple signal transduction pathways. J Biol Chem (1998) 2.88
Hyperalgesic agents increase a tetrodotoxin-resistant Na+ current in nociceptors. Proc Natl Acad Sci U S A (1996) 2.84
A novel nociceptor signaling pathway revealed in protein kinase C epsilon mutant mice. Neuron (1999) 2.82
HTLV-III in symptom-free seronegative persons. Lancet (1984) 2.71
Hemolytic anemia and erythroleukemia, two distinct pathogenic effects of Friend MuLV: mapping of the effects to different regions of the viral genome. Cell (1986) 2.69
The effectiveness of safety belts in preventing fatalities. Accid Anal Prev (1986) 2.64
Long-term symptomless HIV-1 infection in recipients of blood products from a single donor. Lancet (1992) 2.60
Medical accidents: no such thing? BMJ (1993) 2.54
Antinociceptive and motor effects of delta/mu and kappa/mu combinations of intrathecal opioid agonists. Pain (1992) 2.49
Serious or fatal driver injury rate versus car mass in head-on crashes between cars of similar mass. Accid Anal Prev (1987) 2.40
Human immunodeficiency virus type 1 challenge of chimpanzees immunized with recombinant envelope glycoprotein gp120. Proc Natl Acad Sci U S A (1988) 2.34
Influence of the centrosome on the structure of nucleated microtubules. J Cell Biol (1985) 2.33
Association of human T lymphotropic virus type III antibodies with sexual and other behaviors in a cohort of homosexual men from Boston with and without generalized lymphadenopathy. Am J Med (1986) 2.33
Effect of recombinant human granulocyte-macrophage colony-stimulating factor on myelopoiesis in the acquired immunodeficiency syndrome. N Engl J Med (1987) 2.31
Kappa-opioids produce significantly greater analgesia in women than in men. Nat Med (1996) 2.27
Double pair comparison--a new method to determine how occupant characteristics affect fatality risk in traffic crashes. Accid Anal Prev (1986) 2.22
Altered surfactant homeostasis and alveolar type II cell morphology in mice lacking surfactant protein D. Proc Natl Acad Sci U S A (1998) 2.22
Intra-blood-brain-barrier synthesis of HTLV-III-specific IgG in patients with neurologic symptoms associated with AIDS or AIDS-related complex. N Engl J Med (1985) 2.20
Chronic hypersensitivity for inflammatory nociceptor sensitization mediated by the epsilon isozyme of protein kinase C. J Neurosci (2000) 2.20
Measurement of fidelity in psychiatric rehabilitation. Ment Health Serv Res (2000) 2.17
Identification and characterization of a novel related adhesion focal tyrosine kinase (RAFTK) from megakaryocytes and brain. J Biol Chem (1995) 2.17
Gemcitabine alone or in combination with cisplatin in patients with advanced or metastatic cholangiocarcinomas or other biliary tract tumours: a multicentre randomised phase II study - The UK ABC-01 Study. Br J Cancer (2009) 2.13
Mechanical transduction by rat dorsal root ganglion neurons in vitro. Neurosci Lett (1999) 2.11
Biological properties of a CD4 immunoadhesin. Nature (1990) 2.05
The dominant role of driver behavior in traffic safety. Am J Public Health (1996) 1.99
Glutathione redox cycle protects cultured endothelial cells against lysis by extracellularly generated hydrogen peroxide. J Clin Invest (1984) 1.94
Functional isolation and characterization of human hematopoietic stem cells. Science (1995) 1.92
Epinephrine produces a beta-adrenergic receptor-mediated mechanical hyperalgesia and in vitro sensitization of rat nociceptors. J Neurophysiol (1999) 1.92
Characterization of six voltage-gated K+ currents in adult rat sensory neurons. J Neurophysiol (1996) 1.91
Suppression of in vitro haematopoiesis following human immunodeficiency virus infection. Nature (1987) 1.91
Recombinant human erythropoietin for patients with AIDS treated with zidovudine. N Engl J Med (1990) 1.89
Seroepidemiology of human T-lymphotropic virus type III among homosexual men with the acquired immunodeficiency syndrome or generalized lymphadenopathy and among asymptomatic controls in Boston. Ann Intern Med (1985) 1.89
Human T-lymphotropic virus type III in high-risk, antibody-negative homosexual men. Ann Intern Med (1986) 1.88
Modulation of TTX-R INa by PKC and PKA and their role in PGE2-induced sensitization of rat sensory neurons in vitro. J Neurosci (1998) 1.88
A new role for cryptochrome in a Drosophila circadian oscillator. Nature (2001) 1.85
Contribution of sensory afferents and sympathetic efferents to joint injury in experimental arthritis. J Neurosci (1986) 1.84
Prolonged zidovudine therapy in patients with AIDS and advanced AIDS-related complex. AZT Collaborative Working Group. JAMA (1989) 1.84
Microtubule behavior during guidance of pioneer neuron growth cones in situ. J Cell Biol (1991) 1.83
Haematologic manifestations of the human immune deficiency virus (HIV). Br J Haematol (1987) 1.83
One-year results of the Thrombolysis in Myocardial Infarction investigation (TIMI) Phase II Trial. Circulation (1992) 1.82
The safety and pharmacokinetics of recombinant soluble CD4 (rCD4) in subjects with the acquired immunodeficiency syndrome (AIDS) and AIDS-related complex. A phase 1 study. Ann Intern Med (1990) 1.82
CD4+ lymphocyte function with early human immunodeficiency virus infection. Proc Natl Acad Sci U S A (1989) 1.78
Intraneuronal substance P contributes to the severity of experimental arthritis. Science (1984) 1.77
Systemic morphine suppresses noxious stimulus-evoked Fos protein-like immunoreactivity in the rat spinal cord. J Neurosci (1990) 1.77
Physical restraint use and falls in nursing home residents. J Am Geriatr Soc (1996) 1.71
A tetrodotoxin-resistant sodium current mediates inflammatory pain in the rat. Neurosci Lett (1998) 1.67
The narcotic antagonist naloxone enhances clinical pain. Nature (1978) 1.66
Characterization of serum neutralization response to the human immunodeficiency virus (HIV). AIDS Res Hum Retroviruses (1987) 1.65
Role of interleukin-6 in chronic muscle hyperalgesic priming. Neuroscience (2008) 1.65
Naloxone dose dependently produces analgesia and hyperalgesia in postoperative pain. Nature (1979) 1.63
Role of protein kinase A in the maintenance of inflammatory pain. J Neurosci (1999) 1.63
Leukotriene and prostaglandin sensitization of cutaneous high-threshold C- and A-delta mechanonociceptors in the hairy skin of rat hindlimbs. Neuroscience (1987) 1.62
Mediation of primary afferent peripheral hyperalgesia by the cAMP second messenger system. Neuroscience (1989) 1.62
Production of tumor necrosis factor alpha and interleukin 1 beta by monocytic cells infected with human immunodeficiency virus. J Clin Invest (1989) 1.61
Molecular analysis of mammalian timeless. Neuron (1998) 1.60
Effect of sympathetic activity on capsaicin-evoked pain, hyperalgesia, and vasodilatation. Neurology (1999) 1.59
The problem of non-compliance with drug therapy. Drugs (1983) 1.59
Enzymic degradation of cartilage in osteoarthritis. Fed Proc (1973) 1.57
Further confirmation of the role of adenyl cyclase and of cAMP-dependent protein kinase in primary afferent hyperalgesia. Neuroscience (1991) 1.54
Co-expression of nociceptor properties in dorsal root ganglion neurons from the adult rat in vitro. Neuroscience (1996) 1.53
Survival and functional outcome of children requiring endotracheal intubation during therapy for severe traumatic brain injury. Crit Care Med (1997) 1.53
Leukotriene B4 produces hyperalgesia that is dependent on polymorphonuclear leukocytes. Science (1984) 1.53
The histiocytic disorders: a pathophysiologic analysis. Ann Intern Med (1981) 1.50
Nociceptor sensitization by extracellular signal-regulated kinases. J Neurosci (2001) 1.49
Serological characterization of HTLV-III infection in AIDS and related disorders. J Infect Dis (1986) 1.47
Chemokine receptors CXCR-1/2 activate mitogen-activated protein kinase via the epidermal growth factor receptor in ovarian cancer cells. J Biol Chem (2000) 1.46
Immune (gamma) interferon produced by a human T-lymphoblast cell line. Nature (1981) 1.45
Quantitation of plasma human immunodeficiency virus type 1 RNA by competitive polymerase chain reaction. J Infect Dis (1992) 1.44
Pain-induced analgesia mediated by mesolimbic reward circuits. J Neurosci (1999) 1.44
Extravasation of liposomal daunorubicin in patients with AIDS-associated Kaposi's sarcoma: a report of four cases. Oncol Nurs Forum (1998) 1.44
Effects of a restraint reduction intervention and OBRA '87 regulations on psychoactive drug use in nursing homes. J Am Geriatr Soc (1997) 1.44